Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with...
35 insider purchases on record · latest filing 2026-05-29.
Insiders have also filed 70 sale transactions at ANNX.